Plasma fibronectin in peripheral arterial disease.

Area of Science:

• Biochemistry
• Vascular Biology
• Metabolic Disorders

Background:

• Peripheral arterial disease (PAD) and atherosclerosis involve complex pathophysiological processes.
• Understanding specific protein markers like fibronectin and factor VIII related antigen is crucial for disease characterization.

Purpose of the Study:

• To investigate plasma fibronectin levels in patients with peripheral arterial disease and obliterative atherosclerosis of the lower limbs.
• To compare these levels with those in normal weight, normolipidemic controls and normolipidemic PAD patients.

Main Methods:

• Plasma fibronectin levels were measured using established biochemical assays.
• Factor VIII related antigen levels were assessed in patients with PAD.
• Patient groups included controls, PAD patients, and hyperlipidemic patients with lower limb atherosclerosis.

Main Results:

• Plasma fibronectin levels were not significantly different between normolipidemic control subjects and patients with peripheral arterial disease.
• Endothelial cell-derived factor VIII related antigen was significantly increased in PAD patients.
• Hyperlipidemic patients with lower limb atherosclerosis exhibited significantly higher plasma fibronectin levels compared to both controls and normolipidemic PAD patients.

Conclusions:

• Elevated plasma fibronectin in hyperlipidemic patients with lower limb atherosclerosis is likely associated with altered hepatic protein synthesis.
• The findings suggest that increased fibronectin is not directly indicative of ongoing arterial lesions in this context.
• Metabolic factors, particularly hypertriglyceridemia and overweight status, may play a significant role in fibronectin elevation.